This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Interval-training and Appetite Regulation in Patie...
Clinical trial

Interval-training and Appetite Regulation in Patients With Type 2 Diabetes

Read time: 2 mins
Last updated:1st Oct 2015

Four months of interval walking (IW) training results in substantial weight loss in opposition to energy-expenditure matched continuous walking (CW) training. The reason for this is unclear.

This study will assess if IW leads to greater exercise-induced suppression of appetite and ad libitum food intake compared to CW and no exercise.

Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions:

    1. One hour of rest (CON)
    2. One hour of interval walking (repeated cycles of 3 min of fast and 3 min of slow walking; IW)
    3. One hour of continuous walking (CW) matched to IW with regards to energy-expenditure.

After the interventions subjects will undergo a liquid mixed meal tolerance test (450 kCal), with regular measurements of appetite-related hormones (insulin, ghrelin, Leptin, Cholecystokinin, PYY). Three hours into the mixed meal tolerance test, a standardised ad-libitum meal test will be served and intake will recorded. Free-living energy intake via food records will be assessed during the following 32 hours.

Study Type: Interventional
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Interval-training and Appetite Regulation in Patients With Type 2 Diabetes
Estimated Enrollment: 14
Study Start Date: October 2015
Estimated Study Completion Date: October 2016
Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)

- Experimental:
- Experimental: CW
- Experimental: IW

Category Value
Study start date 2015-10-01

View full details